20062-51-5 Usage
Description
1-Methyl-1H-imidazole-2-carboxylic acid amide, also known as N-methylimidazole-2-carboxamide, is a chemical compound with the molecular formula C6H8N2O2. It is a derivative of imidazole, a five-membered heterocyclic compound. This versatile compound is widely used in various applications due to its unique properties.
Uses
Used in Pharmaceutical Industry:
1-Methyl-1H-imidazole-2-carboxylic acid amide is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and medicines. Its ability to form stable complexes with metal ions makes it a valuable component in the creation of active pharmaceutical ingredients.
Used in Agrochemical Industry:
In the agrochemical industry, 1-Methyl-1H-imidazole-2-carboxylic acid amide is used as a precursor for the synthesis of various agrochemicals. Its role in the development of effective and safe pesticides and herbicides is crucial for modern agriculture.
Used in Corrosion Inhibition:
1-Methyl-1H-imidazole-2-carboxylic acid amide is used as a corrosion inhibitor, protecting metal surfaces from degradation and wear. Its application in this field is essential for maintaining the integrity and longevity of metal structures in various industries.
Used as a Catalyst in Polymerization Processes:
1-Methyl-1H-imidazole-2-carboxylic acid amide is utilized as a catalyst in polymerization processes, facilitating the formation of polymers with specific properties. Its use in this capacity is vital for the production of high-quality plastics, fibers, and other polymer-based materials.
Used as a Stabilizer in Chemical Reactions:
1-Methyl-1H-imidazole-2-carboxylic acid amide is used as a stabilizer in various chemical reactions, ensuring the desired outcome and preventing unwanted side reactions. Its stabilizing properties are beneficial in the synthesis of a wide range of chemical products.
Used in Dye and Pigment Production:
In the production of dyes, pigments, and photographic chemicals, 1-Methyl-1H-imidazole-2-carboxylic acid amide is used to create vibrant and stable colorants. Its role in this industry is essential for the creation of high-quality color products used in various applications, such as textiles, paints, and printing inks.
Obtained through Synthetic Processes:
1-Methyl-1H-imidazole-2-carboxylic acid amide is typically obtained through synthetic processes, making it a reliable and consistent compound for use in various industries. Its synthesis allows for the production of this compound in large quantities, ensuring its availability for diverse applications.
Low Toxicity:
1-Methyl-1H-imidazole-2-carboxylic acid amide is considered to be of low toxicity, making it a safer option for use in various industries. Its low toxicity profile is an important factor in its selection for use in pharmaceuticals, agrochemicals, and other applications where safety is a priority.
Check Digit Verification of cas no
The CAS Registry Mumber 20062-51-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,0,6 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 20062-51:
(7*2)+(6*0)+(5*0)+(4*6)+(3*2)+(2*5)+(1*1)=55
55 % 10 = 5
So 20062-51-5 is a valid CAS Registry Number.
20062-51-5Relevant articles and documents
Direct Oxidative Amination of the Methyl C-H Bond in N-Heterocycles over Metal-Free Mesoporous Carbon
Long, Xiangdong,Wang, Jia,Gao, Guang,Nie, Chao,Sun, Peng,Xi, Yongjie,Li, Fuwei
, p. 10902 - 10912 (2021/09/08)
Direct oxidative amination of the sp3C-H bond is an attractive synthesis route to obtain amides. Conventional catalytic systems for this transformation are based on transition metals and complicated synthesis processes. Herein, direct and efficient oxidative amination of the methyl C-H bond in a wide range of N-heterocycles to access the corresponding amides over metal-free porous carbon is successfully developed. To understand the fundamental structure-activity relationships of carbon catalysts, the surface functional groups and the graphitization degree of porous carbon have been purposefully tailored through doping with nitrogen or phosphorus. The results of characterization, kinetic studies, liquid-phase adsorption experiments, and theoretical calculations indicate that the high activity of the carbon catalyst is attributed to the synergistic effect of surface acidic functional groups (hydroxyl/carboxylic acid/phosphate) and more graphene edge structures exposed on the surface of carbon materials with a high graphitization degree, in which the role of acidic functional groups is to adsorb the substrate molecule and the role of the graphene edge structure is to activate O2
Synthesis of pyrrole-imidazole polyamide oligomers based on a copper-catalyzed cross-coupling strategy
Shiga, Naoki,Takayanagi, Shihori,Muramoto, Risa,Murakami, Tasuku,Qin, Rui,Suzuki, Yuta,Shinohara, Ken-ichi,Kaneda, Atsushi,Nemoto, Tetsuhiro
supporting information, p. 2197 - 2200 (2017/04/27)
Pyrrole-imidazole (Py-Im) polyamides are useful tools for chemical biology and medicinal chemistry studies due to their unique binding properties to the minor groove of DNA. We developed a novel method of synthesizing Py-Im polyamide oligomers based on a Cu-catalyzed cross-coupling strategy. All four patterns of dimer fragments could be synthesized using a Cu-catalyzed Ullmann-type cross-coupling with easily prepared monomer units. Moreover, we demonstrated that pyrrole dimer, trimer, and tetramer building blocks for Py-Im polyamide synthesis were accessible by combining site selective iodination of the pyrrole/pyrrole coupling adduct.
INHIBITORS OF HEPATITIS C VIRUS PROTEASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME
-
Page/Page column 143, (2008/06/13)
The present invention provides compounds of formula (I), (II) or (IV), or pharmaceutically acceptable salts and solvates thereof, which are useful as inhibitors of the Hepatitis C virus (HCV) protease enzyme and are also useful for the treatment of HCV infections in HCV--infected mammals, including humans. The present invention also provides pharmaceutical compositions comprising compounds of formula (I), (II) or (IV), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formulas (I), (II) and (IV).
